<DOC>
	<DOCNO>NCT00232375</DOCNO>
	<brief_summary>We test hypothesis insulin therapy rather sulfonylurea ( SU ) treatment preferable outcome reverse preserve beta cell function patient diabetes call slowly progressive insulin-dependent ( type 1 ) diabetes ( SPIDDM ) latent autoimmune diabetes adult ( LADA ) .</brief_summary>
	<brief_title>Intervention Preserve Beta-Cell Function GAD Ab-Positive Diabetes</brief_title>
	<detailed_description>In multicenter , randomize , nonblinded clinical study , 4,089 non-insulin dependent diabetic patient screen glutamic acid decarboxylase autoantibody ( GADAb ) . Sixty GADAb-positive non-insulin require diabetic patient duration diabetes =/ &lt; 5 year assign either SU group ( n = 30 ) Insulin group ( n = 30 ) . Serum C-peptide response annual oral glucose tolerance test follow 57 mean month . The primary endpoint insulin-dependency ( IDDM : integrate C-peptide value [ sigma C-peptide ] &lt; 4 ng/ml ) .</detailed_description>
	<mesh_term>Insulin</mesh_term>
	<criteria>Subjects use SU agent obtain goal good glycemic control . Duration diabetes within 5 year onset ( diagnosis ) . Subjects history hyperglycemia require insulin treatment and/or history ketosis/ketoacidosis exclude . Subjects malignant disease , systemic inflammatory disease , renal liver disorder malabsorption also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>SPIDDM</keyword>
	<keyword>LADA</keyword>
	<keyword>GAD antibody</keyword>
	<keyword>Beta cell function</keyword>
	<keyword>Insulin</keyword>
</DOC>